TREML4 and diabetes mellitus: Interestingly, patients with diabetes mellitus using antidiabetic drugs had a greater likelihood of expressing TREML4 mRNA at levels above the median (OR 3.630, 95% CI 1.238–10.644, p = 0.019 and OR 8.611, 95% CI 2.191–33.851, p = 0.002, respectively), as shown in Table 4.